- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Nuclear medicine slump hits Sopha
The downturn in the U.S. nuclearmedicine market hit Sopha Medical Systems last week. The U.S.subsidiary of French gamma camera maker Sopha Medical said itwould lay off about 9% of its work force in reaction to a declinein gamma camera orders over the
The downturn in the U.S. nuclearmedicine market hit Sopha Medical Systems last week. The U.S.subsidiary of French gamma camera maker Sopha Medical said itwould lay off about 9% of its work force in reaction to a declinein gamma camera orders over the last three quarters.
The nuclear medicine market nosedived in the fourth quarterof 1993, and by most accounts has yet to return to its formerstrength (SCAN 4/6/94). Gamma camera vendors have been scramblingto adapt, including Sopha competitor ADAC Laboratories, whichimplemented a similar downsizing earlier this year (SCAN 5/4/94).
Most of the lost jobs at Sopha will come from production andadministrative support personnel, the Columbia, MD-based companysaid. Sopha has taken pains to avoid impacting customer serviceor R&D, according to president Colin McNaught.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
